CURRENT PHARMACEUTICAL ANALYSIS, vol.17, no.7, pp.919-925, 2021 (SCI-Expanded)
Background: The number of validated quantification methods for rifampicin, a prototypical Oatp inhibitor, in biological rat samples is limited.